261
Views
5
CrossRef citations to date
0
Altmetric
Letters to the Editor

Outcomes of second-line treatment in chronic lymphocytic leukemia – a population-based study from a well defined geographical region between 2003 and 2013

, , , , , , , , & show all
Pages 1219-1223 | Received 10 Jun 2016, Accepted 03 Oct 2016, Published online: 28 Nov 2016
 

Acknowledgements

This study was funded by Janssen-Cilag AB. Additional research funding was provided by the following foundations: The Swedish Cancer Society, The Cancer Society in Stockholm, King Gustav V Jubilee Fund, The Cancer and Allergy Foundation, StratCan Karolinska Institutet, AFA Insurance, The Stockholm County Council, The Swedish Society of Medicine, Blodcancerfonden and Dr Åke Olsson Foundation. We thank Ms Leila Relander for secretarial assistance, Peter Gray, Nicholas Rusbridge of PAREXEL Access Consulting and Dusha Jeyakumaran of Janssen EMEA for editorial support.

Presented in part at the Annual Meeting of the American Society of Hematology, Orlando, FL, Dec 5-8, 2015.

Potential conflict of interest

Anders Österborg and Lotta Hansson have received research grant support and honoraria for scientific lectures from Janssen. Johanna Repits, Frans Søltoft , Joris Diels are previous or present employees at Janssen-Cilag. The other authors declared no conflict of interest. Disclosure forms provided by the authors are available with the full text of this article at http://dx.doi.org/10.1080/10428194.2016.1246727.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.